MENU
FULC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Fulcrum Therapeutics (FULC) Ownership - Who owns Fulcrum Therapeutics?
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
26 Landsdowne Street
Phone
+1 617 651-8851
Employees
76
Web
https://www.fulcrumtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
137.11M
P/E Ratio
N/A
Total Cash
241.02M
Projected Growth
N/A
Total Debt
8.63M
Revenue
80M
Risk (Beta)
2.67
Dividend Yield
N/A
Total Cash/Share
4.47
Total Debt/Equity
N/A
Revenue/Share
1.29 USD as % of share price
Fundamentals
FULC
Capitalization
137M
P/E Ratio
N/A
Risk (Beta)
2.67
Dividend Yield
N/A
Total Cash
241M
Total Cash/Share
4.47
Total Debt
8.63M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.29%
Revenue
80M
ROE
N/A
Book Value
243M
P/B Ratio
0.56
Cash Flow
N/A
Earnings
-0.16
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
54K
Current Ratio
22.63
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-18.24M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-3.75
Shares Held By Institutions
296M
Shares Outstanding - Current
54M
Total Liabilities
17.7M
Total Volume MTD
N/A
Value
1
Gain YTD
-45.745
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
26 Landsdowne Street
Phone
+1 617 651-8851
Employees
76
Web
https://www.fulcrumtx.com